Press releases

• September 10, 2021 - Other press releaseNew data presented at MDS Congress of ABBV-0805 in Parkinson’s disease
• July 30, 2021 - Other press releaseEisai presented latest data from the lecanemab clinical program at AAIC 2021
• July 21, 2021 - Other press releaseLatest data on lecanemab to be presented at Alzheimer’s Association International Conference (AAIC)

Archive

Calendar

• October 21, 2021Interim report January – September 2021
• February 3, 2022Full Year Report 2021

Read more

Interim Report January - June 2021

BioArctic published the company’s Interim Report for the period January – June 2021 on Friday, July 9, 2021, at 08:00 a.m. CEST.

• Report
• Presentation
• Webcast

Read the report

Alzheimer’s disease

Halting the disease progression would lead to great benefits to patients, families and caregivers.

Read more

Parkinson’s disease

The medical need of treatments is high due to the lack of drugs affecting the underlying pathology.

Read more

Neurodegenerative disorders

BioArctic is committed to help people with neurodegenerative disorders

Read more